3 Top Value Stocks to Buy and Hold for 2026
Bristol-Myers SquibbBristol-Myers Squibb(US:BMY) Youtube·2025-12-23 16:00

Core Insights - The article discusses top value stocks to buy and hold for 2026, emphasizing their undervaluation and strong economic moats [1][2] Group 1: Campbell - Campbell has shifted its portfolio from core soup products to snacks, enhancing efficiencies in its supply chain and manufacturing [3] - The company possesses a wide economic moat due to its strong brand portfolio and established retailer relationships, with a long-term forecast of low single-digit annual sales growth despite inflationary pressures [3] - The stock is considered significantly undervalued [4] Group 2: Bristol Myers Squibb - Bristol Myers Squibb has a strong drug portfolio and a robust pipeline, contributing to its wide economic moat rating [4] - The company faces a patent cliff, with 47% of total revenue exposed to patent threats through 2028, but newer therapies are expected to mitigate revenue impacts [5] - The stock is deemed significantly undervalued, with a target price of $66 per share [6] Group 3: Constellation Brands - Constellation Brands has established a wide economic moat through its portfolio of Mexican beer brands and strong distributor relationships [6] - Recent soft demand has affected results, but new product launches, including citrus-flavored and non-alcoholic beers, are expected to appeal to health-conscious consumers [7] - The stock is valued at $220 per share [7]